Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment
<p>Abstract</p> <p>Background</p> <p>Clinical and psychosocial remission amongst persons with schizophrenia is nowadays a defined goal of treatment. This necessitates incorporating quantifiable psychosocial variables with traditional symptomatic data. We aimed to assess...
Main Authors: | Barak Yoram, Aizenberg Dov |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-244X/12/108 |
Similar Items
-
Lurasidone in adolescents with schizophrenia: Sustained remission and recovery during 2 years of open-label treatment
by: M. Tocco, et al.
Published: (2021-04-01) -
Remission of schizophrenia after an EMDR session
by: Claire Granier, et al.
Published: (2022-07-01) -
Psychometric and clinical evaluation of schizophrenia remission criteria in outpatients with psychotic disorders
by: Karolina Sakinyte, et al.
Published: (2023-03-01) -
Early Markers in Resistant Schizophrenia: Effect of the First Antipsychotic Drug
by: Georgi Panov Panov
Published: (2022-03-01) -
Tapered discontinuation vs. maintenance therapy of antipsychotic medication in patients with first-episode schizophrenia: Obstacles, findings, and lessons learned in the terminated randomized clinical trial TAILOR
by: Anne Emilie Stürup, et al.
Published: (2022-07-01)